{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T22:07:09Z","timestamp":1771279629379,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Updates Surg"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s13304-025-02310-1","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T11:35:59Z","timestamp":1751542559000},"page":"219-227","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Liver resection following neoadjuvant immunotherapy: a single center retrospective study"],"prefix":"10.1007","volume":"78","author":[{"given":"Vanja","family":"Podrascanin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Ammann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yawen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelius A.","family":"Thiels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne G.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Truty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael L.","family":"Kendrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rory L.","family":"Smoot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Nagorney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick P.","family":"Starlinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"2310_CR1","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/01.sla.0000141195.66155.0c","volume":"240","author":"RT Poon","year":"2004","unstructured":"Poon RT, Fan ST, Lo CM et al (2004) Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg 240:698\u2013710. https:\/\/doi.org\/10.1097\/01.sla.0000141195.66155.0c","journal-title":"Ann Surg"},{"key":"2310_CR2","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.jamcollsurg.2010.06.005","volume":"211","author":"T Kamiyama","year":"2010","unstructured":"Kamiyama T, Nakanishi K, Yokoo H et al (2010) Perioperative management of hepatic resection toward zero mortality and morbidity: analysis of 793 consecutive cases in a single institution. J Am Coll Surg 211:443\u2013449. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2010.06.005","journal-title":"J Am Coll Surg"},{"key":"2310_CR3","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","volume":"377","author":"JD Wolchok","year":"2017","unstructured":"Wolchok JD, Chiarion-Sileni V, Gonzalez R et al (2017) Overall survival with combined Nivolumab and Ipilimumab in advanced melanoma. N Engl J Med 377:1345\u20131356. https:\/\/doi.org\/10.1056\/NEJMoa1709684","journal-title":"N Engl J Med"},{"key":"2310_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.lungcan.2020.07.001","volume":"147","author":"X Jia","year":"2020","unstructured":"Jia X, Xu H, Geng L et al (2020) Efficacy and safety of neoadjuvant immunotherapy in resectable nonsmall cell lung cancer: A meta-analysis. Lung Cancer 147:143\u2013153. https:\/\/doi.org\/10.1016\/j.lungcan.2020.07.001","journal-title":"Lung Cancer"},{"key":"2310_CR5","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/neuonc\/nox208","volume":"20","author":"A Omuro","year":"2018","unstructured":"Omuro A, Vlahovic G, Lim M et al (2018) Nivolumab with or without Ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143. Neuro Oncol 20:674\u2013686. https:\/\/doi.org\/10.1093\/neuonc\/nox208","journal-title":"Neuro Oncol"},{"key":"2310_CR6","doi-asserted-by":"publisher","first-page":"6390","DOI":"10.3390\/cancers13246390","volume":"13","author":"CL Blomen","year":"2021","unstructured":"Blomen CL, K\u00f6tt J, Hartung TI et al (2021) Combination of immune checkpoint inhibitors and liver-specific therapies in liver-metastatic uveal melanoma: can we thus overcome its high resistance? Cancers 13:6390. https:\/\/doi.org\/10.3390\/cancers13246390","journal-title":"Cancers"},{"key":"2310_CR7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S2468-1253(21)00385-X","volume":"7","author":"TU Marron","year":"2022","unstructured":"Marron TU, Fiel MI, Hamon P et al (2022) Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial. Lancet Gastroenterol Hepatol 7:219\u2013229. https:\/\/doi.org\/10.1016\/S2468-1253(21)00385-X","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2310_CR8","doi-asserted-by":"publisher","first-page":"1352873","DOI":"10.3389\/fimmu.2024.1352873","volume":"15","author":"C Tian","year":"2024","unstructured":"Tian C, Yu Y, Wang Y et al (2024) Neoadjuvant Immune checkpoint inhibitors in hepatocellular carcinoma: a meta-analysis and systematic review. Front Immunol 15:1352873. https:\/\/doi.org\/10.3389\/fimmu.2024.1352873","journal-title":"Front Immunol"},{"key":"2310_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1200\/JCO.2021.39.3_suppl.26","volume":"39","author":"SA Buechler","year":"2021","unstructured":"Buechler SA (2021) Comparison of immune activity profiles of microsatellite instable colon tumors to microsatellite stable tumors having high ColoType CMS1-score. JCO 39:26\u201326. https:\/\/doi.org\/10.1200\/JCO.2021.39.3_suppl.26","journal-title":"JCO"},{"key":"2310_CR10","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1200\/JCO.2022.40.16_suppl.3511","volume":"40","author":"YL Verschoor","year":"2022","unstructured":"Verschoor YL, Van Den Berg J, Beets G et al (2022) Neoadjuvant Nivolumab, Ipilimumab, and celecoxib in MMR-proficient and MMR-deficient colon cancers: Final clinical analysis of the NICHE study. JCO 40:3511\u20133511. https:\/\/doi.org\/10.1200\/JCO.2022.40.16_suppl.3511","journal-title":"JCO"},{"key":"2310_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00534-005-0999-7","volume":"12","author":"SM Strasberg","year":"2005","unstructured":"Strasberg SM (2005) Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg 12:351\u2013355. https:\/\/doi.org\/10.1007\/s00534-005-0999-7","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"2310_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205\u2013213. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae","journal-title":"Ann Surg"},{"key":"2310_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ejso.2020.09.001","volume":"47","author":"JA S\u00f8reide","year":"2021","unstructured":"S\u00f8reide JA, Deshpande R (2021) Post hepatectomy liver failure (PHLF)\u2014recent advances in prevention and clinical management. Eur J Surg Oncol 47:216\u2013224. https:\/\/doi.org\/10.1016\/j.ejso.2020.09.001","journal-title":"Eur J Surg Oncol"},{"key":"2310_CR14","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.surg.2010.12.002","volume":"149","author":"M Koch","year":"2011","unstructured":"Koch M, Garden OJ, Padbury R et al (2011) Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the international study group of liver surgery. Surgery 149:680\u2013688. https:\/\/doi.org\/10.1016\/j.surg.2010.12.002","journal-title":"Surgery"},{"key":"2310_CR15","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1477-2574.2011.00319.x","volume":"13","author":"NN Rahbari","year":"2011","unstructured":"Rahbari NN, Garden OJ, Padbury R et al (2011) Post-hepatectomy haemorrhage: a definition and grading by the international study group of liver surgery (ISGLS). HPB 13:528\u2013535. https:\/\/doi.org\/10.1111\/j.1477-2574.2011.00319.x","journal-title":"HPB"},{"key":"2310_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.100787","volume":"8","author":"V Amoroso","year":"2023","unstructured":"Amoroso V, Gallo F, Alberti A et al (2023) Immune-related adverse events as potential surrogates of immune checkpoint inhibitors\u2019 efficacy: a systematic review and meta-analysis of randomized studies. ESMO Open 8:100787. https:\/\/doi.org\/10.1016\/j.esmoop.2023.100787","journal-title":"ESMO Open"},{"key":"2310_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92:205\u2013216. https:\/\/doi.org\/10.1093\/jnci\/92.3.205","journal-title":"J Natl Cancer Inst"},{"key":"2310_CR18","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/bjc.2014.299","volume":"111","author":"M Sebagh","year":"2014","unstructured":"Sebagh M, Allard M-A, Cunha AS et al (2014) A proposed new method for assessing the pathological response to chemotherapy in resected colorectal liver metastases. Br J Cancer 111:470\u2013476. https:\/\/doi.org\/10.1038\/bjc.2014.299","journal-title":"Br J Cancer"},{"key":"2310_CR19","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","volume":"359","author":"A Ribas","year":"2018","unstructured":"Ribas A, Wolchok JD (2018) Cancer immunotherapy using checkpoint blockade. Science 359:1350\u20131355. https:\/\/doi.org\/10.1126\/science.aar4060","journal-title":"Science"},{"key":"2310_CR20","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/s43018-021-00234-4","volume":"2","author":"WJ Ho","year":"2021","unstructured":"Ho WJ, Zhu Q, Durham J et al (2021) Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity. Nat Cancer 2:891\u2013903. https:\/\/doi.org\/10.1038\/s43018-021-00234-4","journal-title":"Nat Cancer"},{"key":"2310_CR21","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S2468-1253(21)00427-1","volume":"7","author":"AO Kaseb","year":"2022","unstructured":"Kaseb AO, Hasanov E, Cao HST et al (2022) Perioperative Nivolumab monotherapy versus Nivolumab plus Ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial. Lancet Gastroenterol Hepatol 7:208\u2013218. https:\/\/doi.org\/10.1016\/S2468-1253(21)00427-1","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2310_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/cmi.2016.3","volume":"13","author":"MW Robinson","year":"2016","unstructured":"Robinson MW, Harmon C, O\u2019Farrelly C (2016) Liver immunology and its role in inflammation and homeostasis. Cell Mol Immunol 13:267\u2013276. https:\/\/doi.org\/10.1038\/cmi.2016.3","journal-title":"Cell Mol Immunol"},{"key":"2310_CR23","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3389\/fphar.2017.00561","volume":"8","author":"HO Alsaab","year":"2017","unstructured":"Alsaab HO, Sau S, Alzhrani R et al (2017) PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome. Front Pharmacol 8:561. https:\/\/doi.org\/10.3389\/fphar.2017.00561","journal-title":"Front Pharmacol"},{"key":"2310_CR24","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1056\/NEJMoa1816714","volume":"380","author":"BI Rini","year":"2019","unstructured":"Rini BI, Plimack ER, Stus V et al (2019) Pembrolizumab plus Axitinib versus Sunitinib for advanced renal-cell carcinoma. N Engl J Med 380:1116\u20131127. https:\/\/doi.org\/10.1056\/NEJMoa1816714","journal-title":"N Engl J Med"},{"key":"2310_CR25","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/s41379-018-0013-y","volume":"31","author":"Y Zen","year":"2018","unstructured":"Zen Y, Yeh MM (2018) Hepatotoxicity of immune checkpoint inhibitors: a histology study of seven cases in comparison with autoimmune hepatitis and idiosyncratic drug-induced liver injury. Mod Pathol 31:965\u2013973. https:\/\/doi.org\/10.1038\/s41379-018-0013-y","journal-title":"Mod Pathol"},{"key":"2310_CR26","unstructured":"National Cancer Institute (2018) National cancer institute cancer therapy evaluation program: responsible adverse event (AE) Reporting: finding appropriate ae terms. cancer therapy evaluation program 2018."},{"key":"2310_CR27","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/hpb.12069","volume":"15","author":"S Dokmak","year":"2012","unstructured":"Dokmak S, Ft\u00e9riche FS, Borscheid R et al (2012) 2012 Liver resections in the 21st century: we are far from zero mortality. HPB 15:908\u2013915. https:\/\/doi.org\/10.1111\/hpb.12069","journal-title":"HPB"},{"key":"2310_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/bjs.6429","volume":"96","author":"L Capussotti","year":"2008","unstructured":"Capussotti L, Vigan\u00f2 L, Giuliante F et al (2008) Liver dysfunction and sepsis determine operative mortality after liver resection. Br J Surg 96:88\u201394. https:\/\/doi.org\/10.1002\/bjs.6429","journal-title":"Br J Surg"},{"key":"2310_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00423-016-1512-2","volume":"402","author":"S Gilg","year":"2017","unstructured":"Gilg S, Sparrelid E, Isaksson B et al (2017) Mortality-related risk factors and long-term survival after 4460 liver resections in Sweden\u2014a population-based study. Langenbecks Arch Surg 402:105\u2013113. https:\/\/doi.org\/10.1007\/s00423-016-1512-2","journal-title":"Langenbecks Arch Surg"},{"key":"2310_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00535-019-01620-7","volume":"55","author":"Y Eso","year":"2020","unstructured":"Eso Y, Shimizu T, Takeda H et al (2020) Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancers. J Gastroenterol 55:15\u201326. https:\/\/doi.org\/10.1007\/s00535-019-01620-7","journal-title":"J Gastroenterol"},{"key":"2310_CR31","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1200\/JCO.22.02462","volume":"41","author":"P Vikas","year":"2023","unstructured":"Vikas P, Messersmith H, Compton C et al (2023) Mismatch repair and microsatellite instability testing for immune checkpoint inhibitor therapy: ASCO endorsement of college of american pathologists guideline. JCO 41:1943\u20131948. https:\/\/doi.org\/10.1200\/JCO.22.02462","journal-title":"JCO"}],"container-title":["Updates in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-025-02310-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13304-025-02310-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-025-02310-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T21:03:55Z","timestamp":1771275835000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13304-025-02310-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2310"],"URL":"https:\/\/doi.org\/10.1007\/s13304-025-02310-1","relation":{},"ISSN":["2038-131X","2038-3312"],"issn-type":[{"value":"2038-131X","type":"print"},{"value":"2038-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"14 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective study was approved by the Institutional Review Board (IRB) of Mayo Clinic Rochester (IRB#: 22-011911).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The requirement for written informed consent was waived due to the retrospective nature of the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All data were anonymized and handled in accordance with institutional guidelines and ethical standards to ensure patient confidentiality.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data protection"}}]}}